- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 25.25M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $41.61M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $54.12M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.4M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $842.28K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $5.31M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $18.12M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.55M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $6.6M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $49.45M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $61.07M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $11.69M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $24.17M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $27.82M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $41.01M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 24.88M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $1.37M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$17.9M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$18.24M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $4.2M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $251.89K |
| Net Income | Q1 2025 · Mar 31, 2024 | $208.91K |
| Operating Income | Q1 2025 · Mar 31, 2024 | $2.31M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $406.38K |
| Revenue | Q1 2025 · Mar 31, 2024 | $8M |